Stock screenerAll disclosures →
EDGAR →
ARTV
Conviction 82HealthcareScan · Thu, Jun 25, 2026ARTV$8.85-5.10%
ResistanceSupportVol 14Insider buyInsider sell16
5
Vol MA14 923.61K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price8.85
Change-5.10%
Gap+0.11%
Rel volume3.38×
Avg volume778.51K
Avg $ vol6.62M
SMA 208.23
SMA 509.48
SMA 2005.61
Price vs 50-6.67%
Price vs 200+57.65%
MA stackmixed
50/200 cross—
Supertrendup · 7.11
RSI (14)51
MACD hist0.19
MACD crossbull · 9d
Stoch %K / %D57 / 69
ADX (14)24
+DI / −DI25 / 16
RSI divergence—
MACD divergenceBullish
ATR %+10.86%
ADR %10.58%
52w high13.39
52w low1.47
From 52w high-33.94%
Above 52w low+501.70%
New 52w highNo
SqueezeOff
Bollinger width51.68%
%B0.64
Donchian pos57.73%
Donchian high10.50
Donchian low6.59
AVWAP (52w high)9.52
vs AVWAP high-7.10%
AVWAP (52w low)5.92
vs AVWAP low+49.32%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d3.38×
Avg vol (14d)923.61K
Avg vol (20d)778.51K
Avg $ vol (20d)6.62M
Market cap218.62M
RS 3m (vs SPY)+65.95%
RS 6m (vs SPY)+88.89%
RS line new highNo
Trend template6/8
Technical rank77.8
1 week-11.02%
1 month+15.32%
3 months+62.00%
6 months+98.32%
1 year+449.38%
YTD+109.10%
P/E-2.61
P/B2.49
P/S6.64
P/FCF-2.76
EPS-3.43
Div yield—
ROE-95.47%
ROA-79.15%
Debt/Eq—
Current8.16
EV/EBITDA-2.27
Gross margin—
Net margin-254.73%
Rev growth—
EPS growth-28.29%
Price target35.80
Target upside304.75%
Analyst ratingBuy
Institutional69.11%
Ent. value197.66M
Revenue26.66M
Net income-23.52M
Gross profit—
Free cash flow-79.34M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out24.72M
Employees106
ListedFri, Jul 19, 2024
Free float5.69M
Float %23.2%
Short interest1.03M
Days to cover2.0d
Short volume58.6%
Squeeze score73 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.64 · 2 est
Last EPS vs est−$0.95 vs −$0.88
Last surprise-8.0% miss
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank77.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.75
Support6.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ARTV
No recent disclosed trades by Congress in ARTV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ARTV · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-16 | Buy | 124.89K | $1.1M | 2026-06-16 | 2026-06-16 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-15 | Buy | 15.41K | $139K | 2026-06-15 | 2026-06-16 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-12 | Buy | 391.02K | $3.4M | 2026-06-12 | 2026-06-16 |
GC Cell Corp 10% owner · Common Stock · 2026-05-11 | Buy | 1.09M | $12M | 2026-05-11 | 2026-05-28 |
GC Corp. 10% owner · Common Stock · 2026-05-11 | Buy | 347.22K | $4.0M | 2026-05-11 | 2026-05-28 |
GC Corp. 10% owner · Common Stock · 2026-05-11 | Buy | 1.09M | $12M | 2026-05-11 | 2026-05-28 |
GC Cell Corp 10% owner · Common Stock · 2026-05-11 | Buy | 347.22K | $4.0M | 2026-05-11 | 2026-05-28 |
Banerjee Subhashis Chief Medical Officer · Common Stock · 2026-05-19 | Sell | 7.04K | $63K | 2026-05-19 | 2026-05-19 |
Raymon Heather SVP, Research and Development · Common Stock · 2026-05-19 | Sell | 3.1K | $28K | 2026-05-19 | 2026-05-19 |
Bush Jennifer COO, CLO, Compliance Officer · Common Stock · 2026-05-19 | Sell | 8.79K | $79K | 2026-05-19 | 2026-05-19 |
SEC filings
EDGAR filings in ARTV · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.